Why are antidepressants still stigmatised? Many people treat taking a tablet for low mood as a verdict on character, a sign that someone could not cope alone, yet would never think that about a person taking insulin or blood pressure medication. Psychology can explain where that judgement comes from, why it has been so hard to shift, and what it costs the people on the receiving end, who may well be a friend, colleague, or relative who has never mentioned it.
The question has come round again after a widely shared social media post about judging people who take them. This article looks at the research behind that belief, and the evidence on how well these medicines work is covered in a piece asking whether it is time to rethink antidepressants.
Why are antidepressants still stigmatised?
Stigma about depression and stigma about the medication are not the same thing. A 2011 review of 32 studies by João Castaldelli-Maia and colleagues, published in The Journal of Nervous and Mental Disease, found that prejudice against depression differs from prejudice against taking antidepressants. Stigma around the medication was linked to beliefs about emotional weakness, how severe the illness must be, an inability to cope, and doubts that the drugs work.
Put plainly, a prescription can be read as an admission that someone failed to cope, is sicker than they look, or is leaning on a chemical shortcut instead of willpower. Those are moral readings of a medical decision, and they have little to do with whether the treatment helps.
Why the insulin comparison has not settled it
The usual reply is that depression is an illness like diabetes and that nobody mocks a person for taking insulin. The trouble is that the comparison asks people to drop an everyday habit of treating mood as something a strong person should manage by effort alone.
Researchers have tested whether the medical framing works. In a study named after the slogan “a disease like any other”, Bernice Pescosolido and colleagues made a comparison of US surveys from 1996 and 2006, published in The American Journal of Psychiatry. The share of people who attributed major depression to neurobiological causes rose from 54% to 67%, and support for seeing a psychiatrist for depression rose from 75% to 85%. Social distance and perceived danger did not fall significantly, and holding a neurobiological view was generally unrelated to stigma. Where the two were linked, the effect was more rejection, not less.
The authors concluded that this view translates into support for services but not into less stigma, and they suggested shifting towards an emphasis on competence and inclusion. The survey is American, so it shows a pattern rather than a UK verdict.
A 2013 meta-analysis of 28 experiments by Erlend Kvaale, Nick Haslam, and William Gottdiener in Clinical Psychology Review found a similar trade-off. Explanations that put problems down to genes or brain chemistry reduced blame, but they also increased prognostic pessimism, the belief that someone will not get better, and perceived dangerousness, although that last result may reflect publication bias.
Telling people that depression is a brain disease can lift blame, yet it can also suggest that the person is fundamentally different or unlikely to recover. That is my interpretation of the findings, not something these studies tested directly.
Public stigma and self-stigma
Psychologists separate stigma into two layers. Public stigma is what other people think and do, and self-stigma is what happens when someone absorbs those attitudes and turns them on themselves. In a 2004 paper on how stigma interferes with care in American Psychologist, Patrick Corrigan argued that stigma diminishes self-esteem and robs people of social opportunities, and that people may avoid the label of mental illness, and the harm that comes with it, by not seeking or fully taking part in care.
With antidepressants, that could look like someone who is prescribed a medicine but keeps quiet about it or struggles to see themselves as someone who needs it. The Castaldelli-Maia review suggests that stigma attached to the medication could be a target for interventions in its own right.
What the evidence says about antidepressants
The judgement also sits awkwardly with the evidence. A 2018 network meta-analysis of 21 antidepressants in The Lancet by Andrea Cipriani and colleagues pooled 522 trials with 116,477 participants and found that every antidepressant studied worked better than placebo for adults with major depression. The review covered short-term treatment, so it cannot say how any one person will respond.
That does not make these medicines perfect. The NHS overview of antidepressants says they usually take 1 to 2 weeks to start having an effect and up to 8 weeks to work fully, that side effects are common, and that coming off them can cause withdrawal symptoms. Research on why withdrawing from some antidepressants is so hard is a reminder that these are medical questions with biological answers, not tests of character.
Decisions about starting, changing, or stopping any medicine are for the person taking it and their prescriber, and the NHS says not to stop an antidepressant suddenly. This article is not medical advice.
How to talk about it without adding to the stigma
Small changes in how we speak can matter, and the research above points to a few worth trying:
- Drop the weakness language: Calling medication a crutch or a cop-out repeats the belief that the review linked with stigma. Treat it like any other treatment.
- Lead with competence and inclusion: This is the shift Pescosolido’s team suggested, and it means treating someone who takes antidepressants as the same capable person you already knew.
- Keep other people’s health private: Whether someone takes a medicine is theirs to share, and guessing or announcing it takes that choice away.
- Notice your own reaction: If you take medication and feel ashamed, that feeling is self-stigma, it is common, and a GP is a good person to tell.
If you are struggling, speak to your GP, call NHS 111, or ring Samaritans free on 116 123 at any time. If you are in danger or cannot keep yourself safe, call 999.
FAQs
- Are antidepressants a sign of weakness? No. Stigma tied to beliefs about weakness is well documented, but taking a medicine for a health condition says nothing about character, and the largest network meta-analysis found that all 21 antidepressants it studied worked better than placebo for adults with major depression.
- Why do people judge others for taking antidepressants? Research links it to beliefs that medication signals emotional weakness, severe illness, or an inability to cope, and to doubts that the drugs work.
- Is taking antidepressants like taking insulin? Both are medicines for health conditions, and many people find the comparison helpful. But a comparison of US surveys found that seeing depression as biological increased support for treatment without reducing prejudice, so the analogy alone has not removed the stigma.
- What is self-stigma? Self-stigma is when someone takes on society’s negative attitudes and applies them to themselves. Patrick Corrigan argued that it diminishes self-esteem and can lead people to avoid mental health care.
- What should I do if I feel ashamed of taking antidepressants? Shame is common, and it is worth mentioning to your GP or prescriber, who can talk it through with you. Do not stop your medicine without speaking to them first, and if you need support now, call NHS 111 or Samaritans on 116 123.
Takeaway
Antidepressants are still stigmatised partly because a prescription can be read as proof of weakness, and partly because the “illness like any other” argument has changed attitudes towards treatment more than attitudes towards people. The research is clear that the medicines work better than placebo for many adults, and equally clear that judgement can push people away from care. Treat people who take them as you would anyone managing a health condition, and if you are struggling yourself, speak to your GP, NHS 111, or Samaritans on 116 123.
